PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Endocrine-Disrupting Chemicals in Food10.1533/9781845695743.3.35620092009356-380Assessing the risks of endocrine-disrupting chemicalsA. Beronius, C. Rudén, A. Hanberg, J. Garai, H. Håkanssonhttps://api.elsevier.com/content/article/PII:B9781845692186500148?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9781845692186500148?httpAccept=text/plain, http://woodhead.metapress.com/index/R657522801T83833.pdf
Endocrine-Disrupting Chemicals in Food10.1533/9781845695743.3.29120092009291-305Genetics, epigenetics and genomic technologies: importance and application to the study of endocrine-disrupting chemicalsL.R. Ferguson, M. Philpotthttps://api.elsevier.com/content/article/PII:B9781845692186500112?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9781845692186500112?httpAccept=text/plain, http://woodhead.metapress.com/index/W21277823774L32W.pdf
Endocrine-Disrupting Chemicals in Food10.1533/9781845695743.3.21120092009211-258Exposure to endocrine-disrupting chemicals in foodB. Thomsonhttps://api.elsevier.com/content/article/PII:B9781845692186500094?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9781845692186500094?httpAccept=text/plain, http://woodhead.metapress.com/index/L20502P34117W627.pdf
Endocrine-Disrupting Chemicals in Food10.1533/9781845695743.2.12620092009126-148Surveillance of endocrine-disrupting chemicals in foodsM. Rosehttps://api.elsevier.com/content/article/PII:B9781845692186500069?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9781845692186500069?httpAccept=text/plain, http://woodhead.metapress.com/index/T2373LW200422015.pdf
Advances in Pharmacology10.1016/bs.apha.2021.05.0012021202135-71Toxicity testing and endocrine disrupting chemicalsLaura N. Vandenberghttps://api.elsevier.com/content/article/PII:S1054358921000296?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1054358921000296?httpAccept=text/plain
Toxicology10.1016/s0300-483x(02)00473-020022002389-397Scientific issues associated with the validation of in vitro and in vivo methods for assessing endocrine disrupting chemicalsJohn Ashbyhttps://api.elsevier.com/content/article/PII:S0300483X02004730?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0300483X02004730?httpAccept=text/plain
Toxicologic Pathology10.1177/019262330002800312200020003432-437Validation of In Vitro and In Vivo Methods for Assessing Endocrine Disrupting ChemicalsJohn Ashbyhttp://journals.sagepub.com/doi/pdf/10.1177/019262330002800312, http://journals.sagepub.com/doi/pdf/10.1177/019262330002800312
Advances in Pharmacology10.1016/bs.apha.2021.04.00520212021237-277Endocrine disrupting chemicals and the mammary glandLaura N. Vandenberghttps://api.elsevier.com/content/article/PII:S1054358921000272?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1054358921000272?httpAccept=text/plain
Advances in Pharmacology10.1016/bs.apha.2021.04.00620212021485-520Endocrine disrupting chemicals and breast cancer cellsPhilippa D. Darbrehttps://api.elsevier.com/content/article/PII:S1054358921000284?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1054358921000284?httpAccept=text/plain
Advances in Pharmacology10.1016/bs.apha.2021.05.00220212021401-417Endocrine disrupting chemicals and thyroid hormone actionR. Thomas Zoellerhttps://api.elsevier.com/content/article/PII:S1054358921000302?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1054358921000302?httpAccept=text/plain